Patients with central serous chorioretinopathy not only have pachychoroidal disorders but also altered retinal metabolic function.

These data indicate that patients with CSC have altered metabolic function. The presence of disease activity showed the greatest influence on RO measurement, both compared to controls and to those with inactive chronic CSC disease.